Literature DB >> 23066338

Makena or Compounded 17P?

James P Reichmann1.   

Abstract

Year:  2012        PMID： 23066338      PMCID： PMC3462605     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  4 in total

1.  ASHP guidelines on outsourcing sterile compounding services.

Authors:  James R Rinehart; Darrell Chan; Michael Cunningham; Richard E Geller; Gary Grandfield; Susan Heckman; Rich Kruzynski; Terry T Nishizaki
Journal:  Am J Health Syst Pharm       Date:  2010-05-01       Impact factor: 2.637

2.  ACOG Committee Opinion No. 387 November 2007: pharmaceutical compounding.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

3.  Hydroxyprogesterone caproate injection (makena) one year later: to compound or not to compound that is the question.

Authors:  Yesha Patel; Martha M Rumore
Journal:  P T       Date:  2012-07

4.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.